About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Ongoing studies

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Recruiting

4 1
Investigated Drugs:
- Clazakizumab
+16
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Small cell lung cancer
Investigated Drugs:
- Topotecan Hydrochloride
+5
BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Recruiting

2 1
Investigated Diseases:
- Renal disorder
Investigated Drugs:
- [4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
+10
Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated Drugs:
+3
BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus

Recruiting

2 1

+1
A study of navenibart for long-term safety in patients with hereditary angioedema

Recruiting

3 1
Investigated Drugs:
- NAVENIBART
+5
A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

Recruiting

3 1 1 1
Investigated Drugs:
+2
Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
+1
A study to evaluate the safety and effectiveness of budiodarone tartrate in patients with non-permanent atrial fibrillation

Recruiting

4 1 1
A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Recruiting

3 1 1
Investigated Diseases:
- Bladder cancer
- Bladder transitional cell carcinoma
Investigated Drugs:
- (S)-4-(4-(3-CHLORO-4-(1-(5-FLUOROPYRIDIN-2-YL)-2-HYDROXYETHOXY)PYRAZOLO[1,5-A]PYRIDIN-6-YL)-5-METHYL-1H-1,2,3-TRIAZOL-1-YL)PIPERIDINE-1-CARBONITRILE
- Pembrolizumab
+3

#1 Clinical Trials Search in Europe

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy Ul. Szaserow 128, Warsaw, 04-141, Poland

About Specializations

Medical Center localisation

Ongoing studies

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus

A study of navenibart for long-term safety in patients with hereditary angioedema

A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

A study to evaluate the safety and effectiveness of budiodarone tartrate in patients with non-permanent atrial fibrillation

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy Ul. Szaserow 128, Warsaw, 04-141, Poland

About Specializations

Medical Center localisation

Ongoing studies

We use cookies